Drug Trial News

RSS

Research recommends prompt endoscopic removal when children swallow button batteries

Damage to the lining of the stomach can occur quickly when children swallow button batteries; therefore, clinicians should consider prompt endoscopic removal, even when the child is symptom free and the battery has passed safely through the narrow esophagus, according to research presented at Digestive Disease Week® (DDW) 2019.

20 May 2019

New clinical trial to compare effectiveness of injectable drugs and oral medications to treat HIV

Researchers at the University of Colorado Anschutz Medical Campus, working with the National Institutes of Health, will conduct a clinical trial beginning this month to determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills in a population for whom daily adherence has been a challenge.

10 May 2019

UIC to lead $14.6 million, multi-center COPD research project

The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs -- azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication -- is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD.

10 May 2019

Study evaluates long-acting HIV therapy in patients unable to adhere to strict daily regimens

A clinical trial to evaluate long-acting antiretroviral therapy for maintaining HIV suppression in people for whom adhering to conventional daily oral ART has been a challenge has begun at research sites across the United States.

9 May 2019

Early clinical trial of new treatment for severe dry eye disease shows promising results

Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.

7 May 2019

New drug successfully lowers levels of toxic protein that causes Huntington disease

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients.

7 May 2019

NIH-funded trial demonstrates safety of potential treatment in lung transplant patients

A new study, presented today at the American Association for Thoracic Surgery's 99th Annual Meeting, shows that a potential treatment for ischemia- reperfusion injury is safe for humans.

6 May 2019

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder.

3 May 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

USC Norris study focuses on reducing financial barriers to clinical trial enrollment

USC Norris Comprehensive Cancer Center has launched a study to determine how financial assistance for costs associated with clinical trial participation might increase enrollment, particularly among low-income patients and racial and ethnic minorities.

29 Apr 2019

New drug minimizes damage after a heart attack by 60 percent

Scientists have found a potential new drug for treating the heart damage caused by a heart attack by targeting the way the heart reacts to stress.

From Domainex 25 Apr 2019

Drugs for treatment of stroke, vascular dementia show promising results in early trial

Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.

25 Apr 2019

Huge Malaria vaccine trial in Malawi

This week the African nation of Malawi became one of the first of the planned three to launch a pilot trial for a novel vaccine against malaria. The news and the efforts were lauded by the World Health Organization (WHO).

24 Apr 2019

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

"Magic mouthwash," an oral rinse containing diphenhydramine, lidocaine and antacids, significantly reduced pain from oral mucositis, mouth sores, in patients receiving radiation therapy for cancers of the head and neck when compared to plaecbo.

16 Apr 2019

Drug lowers kidney failure risk in diabetic patients, study finds

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

15 Apr 2019

New clinical trial for patients with IBS-D offers real hope and drug free relief

A large clinical trial “RELIEVE-IBS-D” for patients with diarrhea predominant IBS included in the National Institute for Health Research portfolio has started recruitment in England.

12 Apr 2019

New clinical trials to investigate combination immunotherapy for treating advanced cancers

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly-impossible-to-treat cancer into a disease that can be corralled into remission.

8 Apr 2019

Online cannabis oils contain dangerous amounts of psychoactive THC

Scientists have published a review in the BMJ which calls for more research and regulations surrounding CBD oils offered by online sellers, after it was found that most contain the psychoactive ingredient THC.

8 Apr 2019

$Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy$

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.

4 Apr 2019

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma.

1 Apr 2019

Previous
1
...
92
93
94
95
96
97
98
...
1143
Next